Paramètres
- 560pages
- 20 heures de lecture
En savoir plus sur le livre
The last twenty-five years have seen significant advancements in understanding how brain biochemistry affects mood and behavior, leading to improved pharmacological treatments for mental and emotional disorders. Many patients in clinical settings are on medication or could benefit from it, yet many clinicians, including psychologists and counselors, require more information to effectively treat these patients, refer them for psychiatric consultation, and collaborate with psychiatrists. The updated second edition of Gitlin's guide addresses these needs, reflecting major changes in the clinical landscape over the past five years, including the release of DSM-IV and the prevalence of selective serotonin reuptake inhibitors like fluoxetine (Prozac). This edition expands coverage to include attention deficit/hyperactivity disorder and offers updated insights on new antipsychotics for schizophrenia and the rising use of anticonvulsant mood stabilizers for bipolar disorder. Additionally, it incorporates recent findings from brain imaging studies and research on obsessive-compulsive disorder and social phobia, along with important women's health topics such as pregnancy, PMS, postpartum disorders, and breastfeeding. This revised guide remains an essential resource for nonmedical professionals treating mental and emotional disorders.
Achat du livre
The Psychotherapist's Guide to Psychopharmacology, Michael J. Gitlin
- Langue
- Année de publication
- 1996
- product-detail.submit-box.info.binding
- (rigide),
- État du livre
- Bon
- Prix
- 3,99 €
Modes de paiement
Personne n'a encore évalué .
- Titre
- The Psychotherapist's Guide to Psychopharmacology
- Sous-titre
- Second Edition
- Langue
- Anglais
- Auteurs
- Michael J. Gitlin
- Éditeur
- Free Press
- Publié
- 1996
- Format
- rigide
- Pages
- 560
- ISBN10
- 0684827379
- ISBN13
- 9780684827377
- Séries
- Mots clés
- Santé & Médecine, Motivation & Bien-être, Psychologie, Santé mentale, Psychothérapie, Études de médecine
- Description
- The last twenty-five years have seen significant advancements in understanding how brain biochemistry affects mood and behavior, leading to improved pharmacological treatments for mental and emotional disorders. Many patients in clinical settings are on medication or could benefit from it, yet many clinicians, including psychologists and counselors, require more information to effectively treat these patients, refer them for psychiatric consultation, and collaborate with psychiatrists. The updated second edition of Gitlin's guide addresses these needs, reflecting major changes in the clinical landscape over the past five years, including the release of DSM-IV and the prevalence of selective serotonin reuptake inhibitors like fluoxetine (Prozac). This edition expands coverage to include attention deficit/hyperactivity disorder and offers updated insights on new antipsychotics for schizophrenia and the rising use of anticonvulsant mood stabilizers for bipolar disorder. Additionally, it incorporates recent findings from brain imaging studies and research on obsessive-compulsive disorder and social phobia, along with important women's health topics such as pregnancy, PMS, postpartum disorders, and breastfeeding. This revised guide remains an essential resource for nonmedical professionals treating mental and emotional disorders.